Transplant Navigator Dissemination

Primary Aim A. To disseminate and determine the impact of streamlined navigation on wait listing and number of transplants. The navigator will provide tailored information and assistance to help dialysis patients complete the tasks required at each step in the transplant process. In the control group, dialysis patients will continue to get usual care from their nephrologists and dialysis facility personnel.

Hypothesis: Compared to control patients, intervention patients will be significantly more likely to be wait listed or receive a kidney transplant.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Kidney Transplant Renal Failure Chronic Requiring Hemodialysis

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Lutheran Hospital, Fort Wayne, Indiana, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

between the ages of 18-70
receiving in center hemodialysis

Exclusion criteria

less than 18 years of age
older than 70 years of age

Treatment and study plan

navigator

Other

Primary outcomes

The proportion of patients who are wait listed or receive a kidney transplant.

Time frame: approximately 3 years

Sponsors and collaborators

Lead sponsor

Catherine Sullivan

Other

Registry information

Important dates

Study start: 2014
Primary completion: 2017
Study completion: 2017
First posted: Nov 11, 2013
Registry last updated: Mar 22, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed